fda glp-1 warning 2025 november Scam warning: shoppers warned as thousands of social media pages target weight loss drug buyers Myths & Facts: GLP-1 Drugs

Today, the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims &amp

Learn key insights from Springbuk's 2024 Employee Health Trends update on managing expenses while prioritizing employee well-being.

I would love a listen, subscribe, and review if you are interested in this topic

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity

GLP-1 therapies reduce inflammation across organs through rapid, weight-independent immune and metabolic effects.

Everyone is trying to get their hands on the fancy new weight loss drugs which happen to be medications designed for people with diabetes